Edesa Biotech
EDSA
22 hedge funds and large institutions have $4.34M invested in Edesa Biotech in 2025 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 6 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
4.25% less ownership
Funds ownership: 40.88% → 36.63% (-4.2%)
4% less funds holding
Funds holding: 23 → 22 (-1)
39% less capital invested
Capital invested by funds: $7.1M → $4.34M (-$2.76M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
+$263K |
| 2 |
DP
Diadema Partners
Morristown,
New Jersey
|
+$106K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$77.5K |
| 4 |
State Street
Boston,
Massachusetts
|
+$36.6K |
| 5 |
PAP
Persistent Asset Partners
Hong Kong
|
+$24.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$93K |
| 2 |
Renaissance Technologies
New York
|
-$61.8K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$35.6K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$15.6K |
| 5 |
Citigroup
New York
|
-$4.88K |
EDSA Hedge Fund Activity: Q4 2025 in Review
22 of the 8,256 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q4 2025, worth a combined $4.34M — down 39% from $7.1M a quarter earlier.
Fund positioning in EDSA was balanced in Q4 2025: 6 funds opened new positions, 6 closed out, 5 added to existing stakes and 3 trimmed.
The largest buyer was DRW Securities, opening a new position worth an estimated $263K. The largest seller was Commonwealth Equity Services, exiting entirely with an estimated $93K sold.
- 22 institutional investors held Edesa Biotech (EDSA) as of Q4 2025, down from 23 in Q3 2025.
- Funds reported $4.34M of Edesa Biotech stock for Q4 2025, down 39% quarter-over-quarter.
- 6 funds opened new Edesa Biotech positions in Q4 2025 and 6 closed out, a net change of 0 holders.
- The largest Edesa Biotech buyer in Q4 2025 was DRW Securities, an estimated $263K added.
- The largest Edesa Biotech seller in Q4 2025 was Commonwealth Equity Services, an estimated $93K sold.
Based on aggregated 13F filings for Q4 2025.